Related Experiment Video
Updated: Jun 27, 2026

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
Published on: February 16, 2016
Left ventricular noncompaction
1Department of Pediatrics, Faculty of Medicine, Toyama University, Sugitani, Toyama, Japan. fukiko@med.u-toyama.ac.jp
Insights
Left ventricular noncompaction (LVNC) is a genetic heart muscle disease with varied symptoms. Increased detection in adults highlights the need to identify more causative genes beyond known mutations.
Area of Science:
- Cardiology
- Genetics
- Pathology
Background:
- Left ventricular noncompaction (LVNC) is a distinct cardiomyopathy.
- Characterized by prominent trabeculae and deep recesses, it stems from disrupted heart development.
- LVNC is considered a primary genetic cardiomyopathy, though diagnostic criteria are debated.
Purpose of the Study:
- To summarize the current understanding of LVNC.
- To highlight its increasing detection and variable clinical spectrum.
- To discuss the genetic basis and the search for novel causative genes.
Main Methods:
- Review of existing literature on LVNC.
- Analysis of diagnostic criteria and genetic associations.
- Discussion of clinical manifestations and inheritance patterns.
Main Results:
- LVNC detection, especially in adults, has increased.
- Clinical presentations range from asymptomatic to severe heart failure, arrhythmias, and thromboembolism.
- Genetic heterogeneity is evident, with mutations in ZASP, DTNA, and TAZ linked to LVNC.
Conclusions:
- LVNC diagnosis and criteria require further clarification.
- The genetic basis is complex, with known mutations explaining only a fraction of familial cases.
- Further research is needed to identify additional genes responsible for LVNC.
Abstract:
Left ventricular noncompaction (LVNC) is a recently defined cardiomyopathy characterized by a pattern of prominent trabecular meshwork and deep intertrabecular recesses, and is thought to be caused by arrest of normal endomyocardial morphogenesis. Although LVNC has been classified as a primary cardiomyopathy of genetic origin, its definition and diagnostic criteria are still being debated. Isolated LVNC was thought to be rare; however, heightened awareness has resulted in an increased detection of the morphological features of LVNC in routine clinical practice, especially in the adult population. Clinical manifestations are highly variable, ranging from no symptoms to disabling congestive heart failure, arrhythmias, and systemic thromboemboli. LVNC, like other forms of inherited cardiomyopathy, is genetically heterogeneous and can be inherited as an autosomal-dominant or X-linked recessive disorder. It has been linked to mutations in several genes, including LIM domain binding protein 3 (ZASP), alpha-dystrobrevin (DTNA), tafazzin (TAZ/G4.5) and those encoding sarcomeric proteins. However, the relatively small contribution of known mutations to the disease, compared with the higher proportion of familial cases suggests that other elusive genes remain to be identified.
More Related Videos
09:40Induction of Right Ventricular Failure by Pulmonary Artery Constriction and Evaluation of Right Ventricular Function in Mice
Published on: May 13, 2019
03:40Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
Published on: January 17, 2025
Related Concept Videos
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Mitral Stenosis I: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy